FDA Drugs (New Approvals & NDA)Original article
FDA Rare Disease Framework Initiative Public Meeting - 10/28/2026
Neutral
AI Analysis
Summary
The FDA is convening a hybrid public meeting on October 28, 2026, in partnership with the Reagan-Udall Foundation to gather input on its Rare Disease Framework Initiative for reimagining the agency's approach to rare disease drug development.
Importance:2/10
Sentiment:
0.00
FDArare diseasepublic meetingregulatory framework
Read the original article
Published by FDA Drugs (New Approvals & NDA) on October 15, 2026 3:20 PM